16 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... duration same as for treatment ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... Leishmaniasis #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention ... #Treatment #management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
bradycardia, urinary retention ... Opthaloplegia • Ataxia ... Electrodiagnostic studies - EMG ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... Infections in HIV-AIDS Preventing ... other factors (e.g ... Cytomegalovirus #CMV #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg ... • Continue treatment ... HerpesSimplex #HSV #IDSA ... #Prevention #Treatment
A wandering atrial pacemaker, (WAP), is an atrial arrhythmia that occurs when the natural cardiac pacemaker
(SA node), the atria ... identifiable on ECG ... symptoms or requires treatment ... Clinical #MedStudent #EKG ... WanderingAtrialPacemaker #ECGEducator